tirzepatide molecule File:Tirzepatide structure.svg Tirzepatide: Twincretins as Targeted Therapy

Retatrutide (development code LY3437943 ) is an experimental peptide drug that activates three different metabolic receptors at once hence tri-agonist. It sits a step beyond single-target (GLP-1) semaglutide and dual-target (GIP + GLP-1) tirzepatide

Curr Pharm des 23(24):35503566

Keep the medication at room temperature (do not store above 30C) and away from direct sunlight

Novo Nordisk has completed six Phase IIIa studies of semaglutide injection and submitted a new medicine operation for formerly-daily injectable semaglutide to the U.S

E.2008Magnetic resonance elastography for the noninvasive staging of liver fibrosis